The United Laboratories International Holdings Limited (ULIHF)

ULIHF Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	9,014	6,330	4,262	4,743	3,331	2,997
Cash & Short-Term Investments	9,014	6,330	4,262	4,743	3,331	2,997
Cash Growth	37.52%	48.52%	-10.14%	42.39%	11.15%	-5.31%
Accounts Receivable	5,232	5,726	5,863	4,476	3,424	2,953
Other Receivables	499.25	546.36	451.76	435.88	376.25	406.66
Receivables	5,731	6,272	6,314	4,912	3,800	3,359
Inventory	2,776	2,434	2,238	2,164	2,004	1,429
Other Current Assets	781.83	1,034	972.25	696.55	851.39	440.19
Total Current Assets	18,303	16,071	13,787	12,515	9,986	8,225
Property, Plant & Equipment	10,464	9,175	6,874	6,188	6,069	6,373
Long-Term Investments	7.14	7.11	7.8	7.66	0.5	0.5
Goodwill	3.03	3.03	3.03	3.03	3.03	3.03
Other Intangible Assets	251.08	-	1.71	3.41	5.24	8.16
Long-Term Deferred Tax Assets	77.22	73.68	80.8	80.03	82.78	78.25
Long-Term Deferred Charges	-	209.2	132.25	96.93	114.58	123.12
Other Long-Term Assets	328.88	294.01	130.28	85.74	69.18	152.72
Total Assets	29,435	25,833	21,017	18,980	16,331	14,964
Accounts Payable	3,902	4,175	4,220	3,558	3,211	2,277
Accrued Expenses	1,307	1,100	782.08	797.29	672.55	539.95
Short-Term Debt	-	16.88	23.85	251.38	18.35	26.49
Current Portion of Long-Term Debt	1,389	813.5	174	1,108	1,597	880.65
Current Portion of Leases	4.99	4.78	2.51	3.74	3.87	1.69
Current Income Taxes Payable	194.56	204.35	232.55	209.48	108.09	180.2
Current Unearned Revenue	91.12	132.61	156.93	184.93	164.03	135.38
Other Current Liabilities	2,817	2,325	1,035	919.8	760.31	818.01
Total Current Liabilities	9,706	8,773	6,627	7,033	6,535	4,860
Long-Term Debt	3,722	2,308	1,299	1,096	221.21	1,307
Long-Term Leases	9.91	12.67	4.32	3.9	7.13	-
Long-Term Unearned Revenue	22.82	22.21	32.24	43.41	55.32	65.35
Long-Term Deferred Tax Liabilities	361.05	282.49	288.08	194.07	172.31	119.58
Other Long-Term Liabilities	-	-	19.19	-	-	-
Total Liabilities	13,822	11,398	8,270	8,370	6,991	6,352
Common Stock	16.97	16.97	16.97	16.97	17.13	17.18
Additional Paid-In Capital	-	3,722	3,722	3,722	3,782	3,806
Retained Earnings	-	8,752	7,283	5,328	5,274	4,507
Treasury Stock	-	-1.04	-	-	-17.82	-
Comprehensive Income & Other	15,550	1,898	1,712	1,540	284.78	284.31
Total Common Equity	15,567	14,388	12,735	10,608	9,340	8,614
Minority Interest	46.15	46.96	12.84	1.35	-0.58	-2.07
Shareholders' Equity	15,613	14,435	12,748	10,609	9,340	8,612
Total Liabilities & Equity	29,435	25,833	21,017	18,980	16,331	14,964
Total Debt	5,126	3,156	1,504	2,463	1,848	2,216
Net Cash (Debt)	3,889	3,174	2,758	2,280	1,483	780.89
Net Cash Growth	-5.11%	15.07%	20.96%	53.75%	89.92%	-
Net Cash Per Share	2.14	1.75	1.52	1.25	0.81	0.44
Filing Date Shares Outstanding	1,817	1,817	1,817	1,817	1,829	1,840
Total Common Shares Outstanding	1,817	1,817	1,817	1,817	1,829	1,840
Working Capital	8,598	7,298	7,160	5,482	3,451	3,365
Book Value Per Share	8.57	7.92	7.01	5.84	5.11	4.68
Tangible Book Value	15,313	14,385	12,730	10,602	9,332	8,603
Tangible Book Value Per Share	8.43	7.92	7.01	5.83	5.10	4.67
Land	-	5,220	4,917	4,543	4,458	4,402
Machinery	-	9,213	8,417	8,103	7,873	7,688
Construction In Progress	-	1,856	413.51	264.2	120.65	137.16

Source: S&P Global Market Intelligence. Standard template. Financial Sources.